Oregon

The Board of Pharmacy permanently adopted the following rules at the October 2023 Board Meeting effective October 17, 2023, unless otherwise noted:  

• Division 007 related to Compliance w/OHA COVID-19 rules – Repealed  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist  
• Division 045 related to USP (United States Pharmacopeia) <795> and USP <797> Standards adopted by Reference  
• Division 115 related to Short-acting Opioid Antagonist – Effective March 1, 2024 

Also in Oregon, the Board of Pharmacy announced the agency’s new director, Jamal Fox. Fox has more than 20 years of experience in the public and private sectors. Fox will start his new role with the agency beginning October 25. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.